Inovio Pharmaceuticals, Inc. (LON:0A43)
London
· Delayed Price · Currency is GBP · Price in USD 1.739
0.00 (0.00%)
At close: Apr 17, 2025
Inovio Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -107.25 | -135.12 | -279.82 | -303.66 | -166.41 | Upgrade
|
| Depreciation & Amortization | 3.13 | 3.5 | 5.5 | 4.73 | 4.63 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.02 | 0.32 | 1.07 | - | -4.09 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 12.5 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.86 | -5.73 | 10.39 | 4.86 | -1.11 | Upgrade
|
| Loss (Gain) on Equity Investments | 1.17 | -0.77 | 4.06 | 0.99 | -31.97 | Upgrade
|
| Stock-Based Compensation | 6.6 | 11.07 | 22.56 | 26.34 | 15.65 | Upgrade
|
| Other Operating Activities | -3.16 | 0.12 | 0.19 | 0.68 | 76.4 | Upgrade
|
| Change in Accounts Receivable | 1.21 | 9.33 | -3.71 | 11.03 | -17.02 | Upgrade
|
| Change in Accounts Payable | -3.37 | -45.99 | 32.61 | 26.14 | 3.25 | Upgrade
|
| Change in Unearned Revenue | -0.11 | -2.45 | -2.12 | -3.01 | 0.56 | Upgrade
|
| Change in Other Net Operating Assets | -0.39 | 28.85 | -6.95 | 16.19 | -57.87 | Upgrade
|
| Operating Cash Flow | -104.08 | -124.37 | -216.22 | -215.71 | -177.98 | Upgrade
|
| Capital Expenditures | -0.49 | -0.32 | -0.97 | -1.23 | -1.52 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.06 | 6.22 | - | - | - | Upgrade
|
| Divestitures | - | - | - | - | -2.77 | Upgrade
|
| Investment in Securities | 104.5 | 81.46 | 110.56 | -174.11 | -54.5 | Upgrade
|
| Investing Cash Flow | 104.07 | 87.36 | 109.59 | -175.34 | -58.8 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 0.17 | Upgrade
|
| Long-Term Debt Repaid | -16.42 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -16.42 | - | - | - | 0.17 | Upgrade
|
| Issuance of Common Stock | 36.1 | 5.46 | 83.24 | 216.11 | 466.76 | Upgrade
|
| Repurchase of Common Stock | -0.42 | -0.47 | -1.4 | -4.61 | -4.03 | Upgrade
|
| Other Financing Activities | 32.21 | - | - | - | 2.38 | Upgrade
|
| Financing Cash Flow | 51.48 | 5 | 81.84 | 211.5 | 465.28 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.03 | -0 | -0.03 | -0.03 | 0.03 | Upgrade
|
| Net Cash Flow | 51.5 | -32.02 | -24.81 | -179.58 | 228.53 | Upgrade
|
| Free Cash Flow | -104.56 | -124.69 | -217.18 | -216.94 | -179.5 | Upgrade
|
| Free Cash Flow Margin | -48019.06% | -14986.17% | -2116.34% | -12223.61% | -2422.00% | Upgrade
|
| Free Cash Flow Per Share | -3.85 | -5.62 | -10.92 | -12.47 | -13.88 | Upgrade
|
| Cash Interest Paid | 0.53 | 1.07 | 1.07 | 1.08 | 4.62 | Upgrade
|
| Levered Free Cash Flow | -47.55 | -81.97 | -115.43 | -123.41 | -109.58 | Upgrade
|
| Unlevered Free Cash Flow | -47.44 | -81.21 | -114.64 | -122.2 | -104.14 | Upgrade
|
| Change in Net Working Capital | -13.54 | 16.25 | -15.81 | -36.16 | 45.4 | Upgrade
|
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.